Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0EE8V
|
||||
Former ID |
DNCL003484
|
||||
Drug Name |
JNJ-42756493
|
||||
Indication | Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] | Phase 1/2 | [549426] | ||
Company |
Janssen Research & Development
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Basic fibroblast growth factor receptor 1 | Target Info | Modulator | [543495] | |
KEGG Pathway | MAPK signaling pathway | ||||
Ras signaling pathway | |||||
Rap1 signaling pathway | |||||
PI3K-Akt signaling pathway | |||||
Adherens junction | |||||
Signaling pathways regulating pluripotency of stem cells | |||||
Regulation of actin cytoskeleton | |||||
Pathways in cancer | |||||
Proteoglycans in cancer | |||||
Prostate cancer | |||||
Melanoma | |||||
Central carbon metabolism in cancer | |||||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
FGF signaling pathway | |||||
Pathway Interaction Database | Glypican 1 network | ||||
Syndecan-4-mediated signaling events | |||||
N-cadherin signaling events | |||||
FGF signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.